Company profile: CryoCath
1.1 - Company Overview
Company description
- Provider of cryoablation catheter systems for treating cardiac arrhythmias, tumors, and other obstructions, comprising flexible, steerable catheters supported by electromechanical consoles that deliver and recover refrigerants.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CryoCath
Affera
HQ: United States
Website
- Description: Provider of an integrated platform for cardiac arrhythmia treatment delivering durable therapy for a wide range of patients, and pulsed field ablation for atrial fibrillation using a lattice-tip focal catheter.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affera company profile →
Capricor
HQ: United States
Website
- Description: Provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capricor company profile →
Kestra Medical
HQ: United States
Website
- Description: Provider of wearable medical devices and cloud-based patient data platforms, offering the ASSURE Cardiac Recovery System—a wearable cardioverter defibrillator for detecting and defibrillating ventricular arrhythmias—Kestra CareStation for remote patient progress data and notifications, and the ASSURE Patient App to transmit heart rhythm data and support recovery monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kestra Medical company profile →
TriVascular
HQ: United States
Website
- Description: Provider of new medical devices delivering optimal solutions for endovascular aortic repair (EVAR).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriVascular company profile →
Resverlogix
HQ: Canada
Website
- Description: Provider of biopharmaceutical therapeutics focused on cardiovascular diseases and Alzheimer’s disease, developing apabetalone, a BET protein-inhibiting small molecule targeting cardiovascular disease, diabetes, chronic kidney disease, and vascular cognitive impairment; runs clinical programs including Phase 3 BETonMACE and planned BETonRENAL; supports commercialization via EVERSANA, Shenzhen Hepalink, and Medison Pharma partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resverlogix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CryoCath
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CryoCath
2.2 - Growth funds investing in similar companies to CryoCath
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CryoCath
4.2 - Public trading comparable groups for CryoCath
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →